In the Lab

Special Report

The Medicine Hunters, Part II: Toxic weed fuels a cancer-drug gold rush — and a quandary

By Eric Boodman

In the Lab

7 burning questions now that Biogen has resurrected its ‘failed’ Alzheimer’s drug

By Sharon Begley

Special Report

The Medicine Hunters, Part I: Before signing up for a trial, one patient wants to know if the drug will be affordable

By Eric Boodman

In the Lab

New CRISPR tool has the potential to correct almost all disease-causing DNA glitches, scientists report

By Sharon Begley

In the Lab

Doctors argue for term limits to diversify medical school leadership

By Shraddha Chakradhar

Special Report

Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide

By Sharon Begley

In the Lab

Here’s a brain teaser: Surprising study shows reduced neuronal activity extends life

By Sharon Begley

In the Lab

An ‘unprecedented’ analysis underlines profound failure to study African genomes

By Sharon Begley

In the Lab

Calling embryo editing ‘premature,’ Russian authorities seek to ease fears of a scientist going rogue

By Olga Dobrovidova

In the Lab

What a koala virus tells us about the human genome — and how it defends itself against viral invasions

By Andrew Joseph

In the Lab

Not only who but what: NIH funding disparity between black and white scientists partly driven by research topic

By Shraddha Chakradhar

In the Lab

Three scientists win Nobel Prize in medicine for discovering how cells sense and adapt to oxygen levels

By Sharon Begley

In the Lab

Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment

By Karen Weintraub

Don't Miss

What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets

By Sharon Begley

In the Lab

Major error undermines study suggesting change introduced in the CRISPR babies experiment shortens lives

By Rebecca Robbins

In the Lab

Newly named MacArthur ‘Genius’ and neuroscientist talks creativity in science

By Shraddha Chakradhar

Health

‘I just want to live’: California man pleads with scientists around the world to ‘CRISPR me’

By Sharon Begley

Business

Bayer to invest in Boston lab focused on chronic lung conditions

By Jonathan Saltzman — Boston Globe

In the Lab

To sleep, perchance to forget? Scientists pinpoint in mice the neurons that control memory while dreaming

By Elizabeth Cooney

In the Lab

U.S. awards $3 million to fill gaps in medical marijuana research

By Associated Press

The Watchdogs

Lasker Award recipient had retracted some of his work — a sign of strength, not sloppiness

By Ivan Oransky and Adam Marcus

Health

In a CRISPR first, therapy intended to cure HIV patient appears safe — though ineffective

By Sharon Begley

In the Lab

Why so many cancer drugs fail: Genes thought ‘essential’ for tumor survival are not, study finds

By Sharon Begley

In the Lab

Lasker Awards honor scientists for cancer therapy, immune system work

By Associated Press

In the Lab

Deep-learning AI technique helps scientists see more clearly inside the cell

By Rebecca Robbins

Long-neglected gene plays a bigger role in Alzheimer’s than suspected, study shows

You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers

She was destined to get early Alzheimer’s, but didn’t. Did a rare mutation protect her?

Smaller, lighter, cheaper: A serial entrepreneur wants his portable MRI to transform medicine

The Medicine Hunters, Part II: Toxic weed fuels a cancer-drug gold rush — and a quandary

7 burning questions now that Biogen has resurrected its ‘failed’ Alzheimer’s drug

The Medicine Hunters, Part I: Before signing up for a trial, one patient wants to know if the drug will be affordable

New CRISPR tool has the potential to correct almost all disease-causing DNA glitches, scientists report

Doctors argue for term limits to diversify medical school leadership

Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide

Here’s a brain teaser: Surprising study shows reduced neuronal activity extends life

An ‘unprecedented’ analysis underlines profound failure to study African genomes

Calling embryo editing ‘premature,’ Russian authorities seek to ease fears of a scientist going rogue

What a koala virus tells us about the human genome — and how it defends itself against viral invasions

Not only who but what: NIH funding disparity between black and white scientists partly driven by research topic

Three scientists win Nobel Prize in medicine for discovering how cells sense and adapt to oxygen levels

Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment

What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets

Major error undermines study suggesting change introduced in the CRISPR babies experiment shortens lives

Newly named MacArthur ‘Genius’ and neuroscientist talks creativity in science

‘I just want to live’: California man pleads with scientists around the world to ‘CRISPR me’

Bayer to invest in Boston lab focused on chronic lung conditions

To sleep, perchance to forget? Scientists pinpoint in mice the neurons that control memory while dreaming

U.S. awards $3 million to fill gaps in medical marijuana research

Lasker Award recipient had retracted some of his work — a sign of strength, not sloppiness

In a CRISPR first, therapy intended to cure HIV patient appears safe — though ineffective

Why so many cancer drugs fail: Genes thought ‘essential’ for tumor survival are not, study finds

Lasker Awards honor scientists for cancer therapy, immune system work

Deep-learning AI technique helps scientists see more clearly inside the cell